Funded Tech Companies
Euclises Pharmaceuticals
Euclises Pharmaceuticals is a biopharmaceutical venture, based in St. Louis. Financial backing was provided by private investors, Cultivation Capital and St. Louis Arch Angels.
Company Overview
Company Name
Euclises Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4320 Forest Park Ave. 304
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Euclises Pharmaceuticals, Inc. researches, develops, and commercializes medicines in the field of inflammation and oncology. Euclises Pharmaceuticals, Inc. was formerly known as Talley NewCo, Inc. The company was incorporated in 2011.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/3/2016
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bobby Sandage
Chief Financial Officer
Kathleen Beckmann
Chief Scientific Officer
John Talley
Company Investors
- Cultivation Capital (Rick Ryan)
- St. Louis Arch Angels (Robert Calcaterra)
- BioGenerator (Charles Bolten)
- ABC Laboratories
- Helix Fund
- Missouri Technology Corporation
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs